In short, 109’s creators’ stated intent to make psilocybin therapy accessible to help the growing mental health care crisis has resulted in a policy that doesn’t allow for any of it.
A brief sketch of the potential for Rights of Nature legislation to safeguard sacred plant medicines by recognizing them as rights holders unto themselves.
As we move past a phase of “partial eclipse” by psychedelic hype, this critical field is finally well-situated to explore the full spectrum of psychedelic effects.
Psychedelics hold promise to address an array of conditions, but potential benefits may be stratified along the lines of socioeconomic status.
The top ten most-read articles published on Bill of Health in 2022.
We are excited to welcome our inaugural group of affiliated researchers for the Project on Psychedelics Law and Regulation (POPLAR).
While standard doses of psychedelics will ostensibly be higher than a microdose, the question of just how much higher should be the topic of debate.
A mutual understanding of the term “microdosing psychedelics” is needed to conduct accurate research, promote regulations, and educate the wider population.
A spate of recent exposés have detailed the proliferation of abuse in psychedelic therapy, underscoring the urgent need for ethical guidance.
On Tuesday, Washington State legislators filed a bill that would legalize the supported adult use of psilocybin by people 21 years of age and older.
